4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8+ T Cells-Reference-Cited by-同舟云学术

4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8+ T Cells

Published:2013-07-11 Issue:7 Volume:8 Page:e69677
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lee Do Y.,Choi Beom K.,Lee Don G.,Kim Young H.,Kim Chang H.,Lee Seung J.,Kwon Byoung S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death;JC Hurtado;J Immunol,1997

2. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses;ES Halstead;Nat Immunol,2002

3. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1;HW Lee;J Immunol,2002

4. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1;HW Lee;Eur J Immunol,2003

5. Immunotherapy of cancer with 4-1BB;DS Vinay;Mol Cancer Ther,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of co-signaling receptor modulation in hepatitis B;Cell;2024-07

2. Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation;2024-03-04

3. Epigenetics in T-cell driven inflammation and cancer;Seminars in Cell & Developmental Biology;2024-02

4. Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells;2023-12-18

5. 4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01